| Year |
Title |
Altmetric |
| 2023
|
Long-Term Adverse Outcomes in Black Women with Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort.
Circulation.
147:617-619.
2023
|
|
| 2023
|
The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
Cardiovascular Drugs and Therapy.
37:107-116.
2023
|
|
| 2022
|
Apolipoprotein B versus non-high-density lipoprotein cholesterol: is the debate really over?.
European Journal of Preventive Cardiology.
29:2372-2373.
2022
|
|
| 2022
|
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab.
Journal of the American College of Cardiology.
80:2356-2359.
2022
|
|
| 2022
|
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report).
American Journal of Cardiology.
184:7-13.
2022
|
|
| 2022
|
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
Progress in Cardiovascular Diseases.
75:78-82.
2022
|
|
| 2022
|
Primordial Prevention of Atherosclerotic Cardiovascular Disease: A REVIEW OF THE LITERATURE.
Journal of Cardiopulmonary Rehabilitation and Prevention.
42:389-396.
2022
|
|
| 2022
|
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab.
European Journal of Preventive Cardiology.
29:1842-1851.
2022
|
|
| 2022
|
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.
Canadian Journal of Cardiology.
38:1542-1549.
2022
|
|
| 2022
|
Interprofessional Collaborative Practice Improves Access to Care and Healthcare Quality to Advance Health Equity.
Journal for Healthcare Quality.
44:294-304.
2022
|
|
| 2022
|
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes.
Journal of Clinical Lipidology.
16:747-756.
2022
|
|
| 2022
|
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Circulation.
146:657-672.
2022
|
|
| 2022
|
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
American Journal of Medicine.
135:915-918.
2022
|
|
| 2022
|
Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease.
Journal of the American Heart Association.
11.
2022
|
|
| 2022
|
Trends in High-Intensity Statin Therapy After Myocardial Infarction Among U.S. Adults, 2011-2019.
Journal of the American College of Cardiology.
79:1870-1872.
2022
|
|
| 2022
|
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Lancet Diabetes and Endocrinology.
10:330-340.
2022
|
|
| 2022
|
Alirocumab after acute coronary syndrome in patients with a history of heart failure.
European Heart Journal.
43:1554-1565.
2022
|
|
| 2022
|
Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system.
Progress in Cardiovascular Diseases.
71:86-91.
2022
|
|
| 2022
|
Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction.
Journal of Clinical Lipidology.
16:75-82.
2022
|
|
| 2022
|
Hybrid cardiac rehabilitation – The state of the science and the way forward.
Progress in Cardiovascular Diseases.
70:175-182.
2022
|
|
| 2021
|
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.
Cardiovascular Diabetology.
20.
2021
|
|
| 2021
|
An Interprofessional Collaborative Practice Can Reduce Heart Failure Hospital Readmissions and Costs in an Underserved Population.
Journal of Cardiac Failure.
27:1185-1194.
2021
|
|
| 2021
|
Pathophysiological mechanisms underlying excess risk for diabetes and cardiovascular disease in south asians: The perfect storm.
Current Diabetes Reviews.
17.
2021
|
|
| 2021
|
Treatment Thresholds and ASCVD Risk.
Journal of the American College of Cardiology.
78:1508-1510.
2021
|
|
| 2021
|
Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Kidney Medicine.
3:722-731.e1.
2021
|
|
| 2021
|
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction.
Journal of Clinical Lipidology.
15:665-673.
2021
|
|
| 2021
|
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Journal of the American College of Cardiology.
78:421-433.
2021
|
|
| 2021
|
Relation of lipoprotein(a) levels to incident type 2 diabetes and modification by alirocumab treatment.
Diabetes reviews (Alexandria, Va.).
44:1219-1227.
2021
|
|
| 2021
|
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial..
European Journal of Preventive Cardiology.
28:33-43.
2021
|
|
| 2021
|
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
Circulation.
143:1109-1122.
2021
|
|
| 2021
|
Prior oral contraceptive use and longer term mortality outcomes in women with suspected ischemic heart disease.
Journal of Women's Health.
30:377-384.
2021
|
|
| 2021
|
Trends in Recurrent Coronary Heart Disease after Myocardial Infarction among US Women and Men between 2008 and 2017.
Circulation.
143:650-660.
2021
|
|
| 2021
|
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: Insights from the ODYSSEY OUTCOMES trial.
European Journal of Preventive Cardiology.
28:33-43.
2021
|
|
| 2020
|
The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.
Circulation.
142:2402-2404.
2020
|
|
| 2020
|
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering:ODYSSEY OUTCOMES trial.
European Heart Journal.
41:4245-4255.
2020
|
|
| 2020
|
Response by Schwartz et al to Letter Regarding Article, “Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial”.
Circulation.
142:E335-E336.
2020
|
|
| 2020
|
Association of Internet Use With the Use of Addictive Substances in the United States.
American Journal of Cardiology.
135:182-183.
2020
|
|
| 2020
|
Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
Journal of the American College of Cardiology.
76:2197-2207.
2020
|
|
| 2020
|
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: Prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
European Heart Journal.
41:4114-4123.
2020
|
|
| 2020
|
Sex Differences in Incident and Recurrent Coronary Events and All-Cause Mortality.
Journal of the American College of Cardiology.
76:1751-1760.
2020
|
|
| 2020
|
Caring for underserved patients with heart failure during the COVID-19 pandemic.
Journal of Health Care for the Poor and Underserved.
31:1061-1066.
2020
|
|
| 2020
|
Psychological stress, cardiac symptoms, and cardiovascular risk in women with suspected ischaemia but no obstructive coronary disease.
Stress and Health.
36:264-273.
2020
|
|
| 2020
|
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: An ODYSSEY OUTCOMES trial analysis.
European Heart Journal.
41:2248-2258.
2020
|
|
| 2020
|
Addressing Social Determinants of Health in the Care of Patients with Heart Failure: A Scientific Statement from the American Heart Association.
Circulation.
141:e841-e863.
2020
|
|
| 2020
|
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
Circulation.
141:1608-1617.
2020
|
|
| 2020
|
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.
Journal of the American College of Cardiology.
75:2297-2308.
2020
|
|
| 2020
|
When Diastole Lets You Down: Clinical Relevance of a Widened Pulse Pressure.
Canadian Journal of Cardiology.
36:593-595.
2020
|
|
| 2020
|
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE)
2020
|
|
| 2020
|
Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction.
Journal of Clinical Lipidology.
14:260-270.
2020
|
|
| 2020
|
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES.
Journal of the American College of Cardiology.
75:448-451.
2020
|
|
| 2020
|
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
Journal of the American College of Cardiology.
75:133-144.
2020
|
|
| 2020
|
JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes.
Journal of Clinical Lipidology.
14:4-15.
2020
|
|
| 2020
|
Predicted versus observed major adverse cardiac event risk in women with evidence of ischemia and no obstructive coronary artery disease: A report from wise (women’s ischemia syndrome evaluation).
Journal of the American Heart Association.
9.
2020
|
|
| 2019
|
Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.
Circulation.
140:2054-2062.
2019
|
|
| 2019
|
Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention.
Journal of the American Heart Association.
8.
2019
|
|
| 2019
|
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Circulation.
140:1578-1589.
2019
|
|
| 2019
|
Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES Trial.
Circulation: Cardiovascular Quality and Outcomes.
12.
2019
|
|
| 2019
|
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?.
Journal of the American Heart Association.
8.
2019
|
|
| 2019
|
Time to Rethink Prevention of Chronic Kidney Disease?.
Journal of the American College of Cardiology.
74:1477-1479.
2019
|
|
| 2019
|
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.
Journal of the American College of Cardiology.
74:1167-1176.
2019
|
|
| 2019
|
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.
Journal of the American College of Cardiology.
74:1177-1186.
2019
|
|
| 2019
|
Association of Region and Hospital and Patient Characteristics with Use of High-Intensity Statins after Myocardial Infarction among Medicare Beneficiaries.
JAMA Cardiology.
4:865-872.
2019
|
|
| 2019
|
Effects of alirocumab on types of myocardial infarction: Insights from the ODYSSEY OUTCOMES trial.
European Heart Journal.
40:2801-2809.
2019
|
|
| 2019
|
Implications for REDUCE IT in clinical practice.
Progress in Cardiovascular Diseases.
62:395-400.
2019
|
|
| 2019
|
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Lancet Diabetes and Endocrinology.
7:618-628.
2019
|
|
| 2019
|
Effect of Alirocumab on Mortality after Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
Circulation.
140:103-112.
2019
|
|
| 2019
|
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
Journal of the American College of Cardiology.
73:684-693.
2019
|
|
| 2019
|
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial.
Journal of the American College of Cardiology.
73:387-396.
2019
|
|
| 2019
|
Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
Journal of the American College of Cardiology.
73:400-411.
2019
|
|
| 2019
|
In Response.
Anesthesia and Analgesia.
128:E33.
2019
|
|
| 2019
|
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.
Journal of Lipid Research.
60:1946-1952.
2019
|
|
| 2019
|
Trends in statin use among US adults with chronic kidney disease, 1999-2014.
Journal of the American Heart Association.
8.
2019
|
|
| 2018
|
Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study.
PLoS One.
13.
2018
|
|
| 2018
|
Alirocumab and cardiovascular outcomes after acute coronary syndrome.
New England Journal of Medicine.
379:2097-2107.
2018
|
|
| 2018
|
Do Not Smoke, Eat Healthy, and Exercise ∗.
Journal of the American College of Cardiology.
72:2306-2308.
2018
|
|
| 2018
|
Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality.
Neurology.
91:E1741-E1750.
2018
|
|
| 2018
|
A National Study of U.S. Emergency Departments: Racial Disparities in Hospitalizations for Heart Failure.
American Journal of Preventive Medicine.
55:S31-S39.
2018
|
|
| 2018
|
Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Atherosclerosis.
277:186-194.
2018
|
|
| 2018
|
PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease.
Journal of Clinical Lipidology.
12:835-843.
2018
|
|
| 2018
|
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs
2018
|
|
| 2018
|
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Circulation: Cardiovascular Quality and Outcomes.
11:e004652.
2018
|
|
| 2018
|
Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.
Journal of the American College of Cardiology.
71:1729-1737.
2018
|
|
| 2018
|
PCSK9 variants, low-density lipoprotein cholesterol, and neurocognitive impairment reasons for geographic and racial differences in stroke study (REGARDS).
Circulation.
137:1260-1269.
2018
|
|
| 2018
|
Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
Journal of Clinical Lipidology.
12:348-355.e2.
2018
|
|
| 2018
|
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
Circulation.
137:e30-e66.
2018
|
|
| 2018
|
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
2018
|
|
| 2018
|
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
2018
|
|
| 2018
|
Cardiac rehabilitation for women.
Advances in Experimental Medicine and Biology.
1065:565-577.
2018
|
|
| 2017
|
Rivaroxaban with or without aspirin in stable cardiovascular disease.
New England Journal of Medicine.
377:1319-1330.
2017
|
|
| 2017
|
Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiaries.
JAMA Cardiology.
2:890-895.
2017
|
|
| 2017
|
Age and sex disparities in discharge statin prescribing in the stroke belt: Evidence from the reasons for geographic and racial differences in stroke study.
Journal of the American Heart Association.
6.
2017
|
|
| 2017
|
Sudden cardiac death in women with suspected Ischemic Heart Disease, Preserved ejection fraction, and no obstructive coronary artery disease: A report from the Women's Ischemia Syndrome Evaluation Study.
Journal of the American Heart Association.
6.
2017
|
|
| 2017
|
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk): Insights from the Department of Veterans Affairs.
Circulation.
135:2572-2574.
2017
|
|
| 2017
|
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014.
Journal of the American College of Cardiology.
69:2696-2706.
2017
|
|
| 2017
|
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome Evaluation.
American Journal of Medicine.
130:738-743.
2017
|
|
| 2017
|
Racial differences in statin adherence following hospital discharge for ischemic stroke.
Neurology.
88:1839-1848.
2017
|
|
| 2017
|
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
PLoS One.
12.
2017
|
|
| 2017
|
Adoption of the 2013 American College of Cardiology/ American Heart Association Cholesterol Management Guideline in cardiology practices nationwide.
JAMA Cardiology.
2:361-369.
2017
|
|
| 2017
|
Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
Journal of the American College of Cardiology.
69:1386-1395.
2017
|
|
| 2017
|
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)
2017
|
|
| 2017
|
Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes.
American Heart Journal.
183:54-61.
2017
|
|
| 2016
|
Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?.
Circulation.
134:1695-1696.
2016
|
|
| 2016
|
Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
Journal of the American College of Cardiology.
68:985-995.
2016
|
|
| 2016
|
Advanced Imaging and Diagnostic Methods in the Assessment of Suspected Ischemic Heart Disease in Women.
Current Cardiology Reports.
18.
2016
|
|
| 2016
|
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.
Journal of Women's Health.
25:875-881.
2016
|
|
| 2016
|
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Journal of Behavioral Medicine.
39:687-693.
2016
|
|
| 2016
|
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Scientific Reports.
6.
2016
|
|
| 2016
|
Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.
American Journal of Medicine.
129:753.e13-753.e22.
2016
|
|
| 2016
|
Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination.
ESC Heart Failure.
3:11-17.
2016
|
|
| 2016
|
Managing Residual Risk After Myocardial Infarction Among Individuals with Low Cholesterol Levels.
Endocrinology and Metabolism Clinics of North America.
45:171-184.
2016
|
|
| 2016
|
Statins and Cognitive Side Effects: What Cardiologists Need to Know.
Endocrinology and Metabolism Clinics of North America.
45:101-116.
2016
|
|
| 2016
|
Carotid artery distensibility and hormone therapy and menopause: The Los Angeles Atherosclerosis Study
2016
|
|
| 2016
|
Tree-based identification of subgroups for time-varying covariate survival data.
Statistical Methods in Medical Research.
25:488-501.
2016
|
|
| 2016
|
Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.
Circulation.
133:256-264.
2016
|
|
| 2016
|
The impact of statin therapy on plasma levels of von Willebrand factor antigen: Systematic review and meta-analysis of Randomised placebo-controlled trials.
Thrombosis and Haemostasis.
115:520-532.
2016
|
|
| 2015
|
Selecting Patients for Statin Therapy in Primary Prevention if We Could only Predict the Future.
Journal of the American College of Cardiology.
66:2710-2712.
2015
|
|
| 2015
|
The Association Between Life-Space and Health Care Utilization in Older Adults with Heart Failure
2015
|
|
| 2015
|
Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.
Journal of the American College of Cardiology.
66:1864-1872.
2015
|
|
| 2015
|
Comprehensive cardiovascular risk factor control improves survival: The BARI 2D trial.
Journal of the American College of Cardiology.
66:765-773.
2015
|
|
| 2015
|
Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009.
American Heart Journal.
170:249-255.e2.
2015
|
|
| 2015
|
Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities.
Journal of the American College of Cardiology.
65:2652-2659.
2015
|
|
| 2015
|
The National Physical Activity Plan: A Call to Action from the American Heart Association A Science Advisory from the American Heart Association.
Circulation.
131:1932-1940.
2015
|
|
| 2015
|
ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3): A Report of the ACC Competency Management Committee.
Journal of the American College of Cardiology.
65:1721-1723.
2015
|
|
| 2015
|
COCATS 4 task force 2: Training in preventive cardiovascular medicine.
Journal of the American College of Cardiology.
65:1754-1762.
2015
|
|
| 2015
|
Prognostic Significance of Depression in Blacks with Heart Failure: Insights from Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training.
Circulation: Heart Failure.
8:497-503.
2015
|
|
| 2015
|
Managing residual risk after myocardial infarction among individuals with low cholesterol levels.
Cardiology Clinics.
33:299-308.
2015
|
|
| 2015
|
Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking.
Circulation: Heart Failure.
8:694-701.
2015
|
|
| 2015
|
Statins and cognitive side effects. what cardiologists need to know.
Cardiology Clinics.
33:245-256.
2015
|
|
| 2015
|
Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults ≤65 years with heart failure.
American Journal of Cardiology.
115:797-801.
2015
|
|
| 2015
|
Relationship of physical activity and healthy eating with mortality and incident heart failure among community-dwelling older adults with normal body mass index.
ESC Heart Failure.
2:20-24.
2015
|
|
| 2015
|
Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.
American Journal of Cardiology.
115:447-453.
2015
|
|
| 2015
|
Chest Pain Characteristics and Gender in the Early Diagnosis of Acute Myocardial Infarction.
Current Cardiology Reports.
17:1-5.
2015
|
|
| 2015
|
Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening.
Current Atherosclerosis Reports.
17.
2015
|
|
| 2015
|
Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.
Journal of the American Heart Association.
4.
2015
|
|
| 2015
|
Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients.
International Journal of Cardiology.
178:111-116.
2015
|
|
| 2015
|
Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials.
Thrombosis and Haemostasis.
114:546-557.
2015
|
|
| 2015
|
Sex, prescribing practices and guideline recommended, blood pressure, and LDL cholesterol targets at baseline in the BARI 2D trial.
International Journal of Endocrinology.
2015.
2015
|
|
| 2015
|
The Role of the Clinical Pharmacist in the Care of Patients with Cardiovascular Disease.
Journal of the American College of Cardiology.
66:2129-2139.
2015
|
|
| 2015
|
Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.
Journal of the American College of Cardiology.
65:270-277.
2015
|
|
| 2014
|
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial.
American Heart Journal.
168:682-689.e1.
2014
|
|
| 2014
|
Observational study: New ACC-AHA cholesterol guidelines significantly increase potential eligibility for statin treatment.
BMJ Evidence Based Medicine.
19:198.
2014
|
|
| 2014
|
Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.
American Journal of Cardiology.
114:826-831.
2014
|
|
| 2014
|
Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia.
American Journal of Medicine.
127:840-847.
2014
|
|
| 2014
|
Lipid-lowering therapy in patients 75 years and older: Clinical priority or superfluous therapy?.
Progress in Cardiovascular Diseases.
57:187-196.
2014
|
|
| 2014
|
Left anterior descending coronary artery occlusion secondary to metastatic squamous cell carcinoma presenting as st-segment-elevation myocardial infarction.
Circulation.
129.
2014
|
|
| 2014
|
Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease.
International Journal of Cardiology.
174:436-439.
2014
|
|
| 2014
|
Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke).
Journal of the American College of Cardiology.
63:1626-1633.
2014
|
|
| 2014
|
Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: A cross-sectional study.
BMC Health Services Research.
14.
2014
|
|
| 2014
|
Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event..
American Journal of Cardiology.
114:826-831.
2014
|
|
| 2014
|
An assessment by the Statin cognitive safety task force: 2014 update.
Journal of Clinical Lipidology.
8.
2014
|
|
| 2014
|
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study..
Journal of the American Heart Association.
3.
2014
|
|
| 2014
|
Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults.
Journal of Clinical Lipidology.
8:86-93.
2014
|
|
| 2014
|
Effects of exercise training on outcomes inwomen with heart failure. Analysis of HF-ACTION (Heart failure-a controlled trialinvestigating outcomes of exercise training) by Sex.
JACC: Heart Failure.
2:180-186.
2014
|
|
| 2014
|
Functional Status and Outcome After Coronary Artery Bypass Grafting.
JACC: Heart Failure.
2:344-346.
2014
|
|
| 2014
|
JCL Roundtable: Lipid-lowering drugs in those older than 75 years of age.
Journal of Clinical Lipidology.
8:533-541.
2014
|
|
| 2013
|
Secondary prevention of atherosclerotic cardiovascular disease in older adults: A scientific statement from the American heart association.
Circulation.
128:2422-2446.
2013
|
|
| 2013
|
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
International Journal of Cardiology.
168:2335-2340.
2013
|
|
| 2013
|
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events.
International Journal of Cardiology.
168:1905-1909.
2013
|
|
| 2013
|
Anginal symptoms, coronary artery disease, and adverse outcomes in black and white women: The NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study.
Journal of Women's Health.
22:724-732.
2013
|
|
| 2013
|
Clinical implications of the Women's Ischemia Syndrome Evaluation: Inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.
Women's Health.
9:479-490.
2013
|
|
| 2013
|
Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010.
American Journal of Cardiology.
112:664-670.
2013
|
|
| 2013
|
Exercise standards for testing and training: A scientific statement from the American heart association.
Circulation.
128:873-934.
2013
|
|
| 2013
|
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study..
Cardiovascular diagnosis and therapy.
3:64-72.
2013
|
|
| 2013
|
Reply.
Journal of the American College of Cardiology.
61:2113.
2013
|
|
| 2013
|
Risk factor control for coronary artery disease secondary prevention in large randomized trials.
Journal of the American College of Cardiology.
61:1607-1615.
2013
|
|
| 2013
|
LDL lowering after acute coronary syndrome: Is lower better?.
Current Treatment Options in Cardiovascular Medicine.
15:33-40.
2013
|
|
| 2013
|
Erratum: Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease (American Heart Journal (2012) 164 (387-393)).
American Heart Journal.
166:197.
2013
|
|
| 2013
|
Race, exercise training, and outcomes in chronic heart failure: Findings from Heart Failure - A Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION).
American Heart Journal.
166.
2013
|
|
| 2012
|
6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure.
Journal of the American College of Cardiology.
60:2653-2661.
2012
|
|
| 2012
|
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: A statement for health care professionals from the American association of cardiovascular and pulmonary rehabilitation and the American Heart Association.
Circulation.
126:2535-2543.
2012
|
|
| 2012
|
Association of race and sex with risk of incident acute coronary heart disease events.
Journal of the American Medical Association.
308:1768-1774.
2012
|
|
| 2012
|
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: A statement for health care professionals from the American association for cardiovascular and pulmonary rehabilitation and the American heart association.
Journal of Cardiopulmonary Rehabilitation and Prevention.
32:410-419.
2012
|
|
| 2012
|
Population approaches to improve diet, physical activity, and smoking habits: A scientific statement from the American heart association.
Circulation.
126:1514-1563.
2012
|
|
| 2012
|
Cardiac rehabilitation: Call to action for healthcare providers.
Circulation.
126:671-673.
2012
|
|
| 2012
|
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute-sponsored women's ischemia syndrome evaluation study.
Psychosomatic Medicine.
74:263-270.
2012
|
|
| 2012
|
Increasing referral and participation rates to outpatient cardiac rehabilitation: The valuable role of healthcare professionals in the inpatient and home health settings: A science advisory from the american heart association.
Circulation.
125:1321-1329.
2012
|
|
| 2012
|
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.
Journal of Women's Health.
21:133-139.
2012
|
|
| 2012
|
Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.
American Heart Journal.
164:387-393.
2012
|
|
| 2011
|
Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: A presidential advisory from the american heart association.
Circulation.
124:2951-2960.
2011
|
|
| 2011
|
Isolated diastolic hypotension and incident heart failure in older adults.
Hypertension.
58:895-901.
2011
|
|
| 2011
|
Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: Modelling study of national mortality data.
British medical journal.
343.
2011
|
|
| 2011
|
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists.
Journal of Clinical Lipidology.
5:338-367.
2011
|
|
| 2011
|
Timing of hormone therapy, type of menopause, and coronary disease in women: Data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation
2011
|
|
| 2011
|
Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association.
Circulation.
123:2292-2333.
2011
|
|
| 2011
|
Gender-related dissociation in outcomes in chronic heart failure: Reduced mortality but similar hospitalization in women.
International Journal of Cardiology.
148:36-42.
2011
|
|
| 2011
|
Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes Trial).
American Journal of Cardiology.
107:980-985.
2011
|
|
| 2011
|
Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
American Journal of Cardiology.
107:898-905.
2011
|
|
| 2011
|
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Obstetrical and Gynecological Survey.
66:143-144.
2011
|
|
| 2011
|
Cardiac rehabilitation outcomes: impact of comorbidities and age..
Journal of Cardiopulmonary Rehabilitation and Prevention.
31:342-348.
2011
|
|
| 2010
|
Prognostic Value of Global MR Myocardial Perfusion Imaging in Women With Suspected Myocardial Ischemia and No Obstructive Coronary Disease: Results From the NHLBI–Sponsored WISE (Women's Ischemia Syndrome Evaluation) Study.
JACC: Cardiovascular Imaging.
3:1030-1036.
2010
|
|
| 2010
|
Exercise as a treatment for the risk of cardiovascular disease.
Current Treatment Options in Cardiovascular Medicine.
12:329-341.
2010
|
|
| 2010
|
Self-rated versus objective health indicators as predictors of major cardiovascular events: The NHLBI-sponsored women's ischemia syndrome evaluation.
Psychosomatic Medicine.
72:549-555.
2010
|
|
| 2010
|
Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial).
American Journal of Cardiology.
105:905-911.
2010
|
|
| 2010
|
Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
American Heart Journal.
159:385-391.
2010
|
|
| 2010
|
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women.
Journal of Clinical Lipidology.
4:324-334.
2010
|
|
| 2010
|
Cardiac rehabilitation and women: What keeps them away?.
Journal of Cardiopulmonary Rehabilitation and Prevention.
30:12-21.
2010
|
|
| 2010
|
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Journal of Clinical Endocrinology and Metabolism.
95:4985-4992.
2010
|
|
| 2010
|
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.
Circulation.
121:252-258.
2010
|
|
| 2010
|
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis study.
Journal of Clinical Endocrinology and Metabolism.
95:4432-4440.
2010
|
|
| 2009
|
Menopause, Age, and Cardiovascular Risk. A Complex Relationship.
Journal of the American College of Cardiology.
54:2374-2375.
2009
|
|
| 2009
|
Biomarkers of atherosclerosis: Clinical applications.
Current Cardiovascular Risk Reports.
3:23-30.
2009
|
|
| 2009
|
Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study.
Heart.
95:1901-1906.
2009
|
|
| 2009
|
Control of lipids at baseline in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.
Preventive Cardiology.
12:9-18.
2009
|
|
| 2009
|
Comorbid depression and anxiety symptoms as predictors of cardiovascular events: Results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study.
Psychosomatic Medicine.
71:958-964.
2009
|
|
| 2009
|
Baseline differences in the HF-ACTION trial by sex.
American Heart Journal.
158.
2009
|
|
| 2009
|
ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease).
Journal of the American College of Cardiology.
54:1364-1405.
2009
|
|
| 2009
|
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the american college of cardiology foundation/american heart association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): Developed in collaboration with the american academy of family physicians.
Circulation.
120:1296-1336.
2009
|
|
| 2009
|
Postmenopausal hormone therapy and the risk of cardiovascular disease.
Expert Opinion on Pharmacotherapy.
10:2041-2053.
2009
|
|
| 2009
|
Total estrogen time and obstructive coronary disease in women: Insights fromthe NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Journal of Women's Health.
18:1315-1322.
2009
|
|
| 2009
|
Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients. Findings From the American Heart Association's Get With The Guidelines Program.
Journal of the American College of Cardiology.
54:515-521.
2009
|
|
| 2009
|
Comparison of baseline characteristics and outcomes in younger and older patients completing cardiac rehabilitation.
Journal of Cardiopulmonary Rehabilitation and Prevention.
29:220-229.
2009
|
|
| 2009
|
Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.
JAMA Psychiatry.
66:499-507.
2009
|
|
| 2009
|
The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: The wise study.
Journal of Women's Health.
18:443-450.
2009
|
|
| 2009
|
Drugs are not enough: The metabolic syndrome - A call for intensive therapeutic lifestyle change.
Journal of the CardioMetabolic Syndrome.
4:20-25.
2009
|
|
| 2009
|
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia. A Report From the Women's Ischemia Syndrome Evaluation (WISE).
American Heart Journal.
157:548-555.
2009
|
|
| 2009
|
The TNT study, women and cancer.
Heart.
95:250.
2009
|
|
| 2009
|
Depression and Cardiovascular Health Care Costs Among Women With Suspected Myocardial Ischemia. Prospective Results From the WISE (Women's Ischemia Syndrome Evaluation) Study.
Journal of the American College of Cardiology.
53:176-183.
2009
|
|
| 2009
|
Assessing patient recall of discharge instructions for acute myocardial infarction..
Journal for Healthcare Quality.
31.
2009
|
|
| 2008
|
Biomarkers of atherosclerosis: Clinical applications.
Current Cardiology Reports.
10:497-504.
2008
|
|
| 2008
|
Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study).
American Journal of Cardiology.
102:1312-1317.
2008
|
|
| 2008
|
Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women.
Journal of General Internal Medicine.
23:1429-1434.
2008
|
|
| 2008
|
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the national institutes of health, national heart, lung and blood institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Journal of Women's Health.
17:1081-1092.
2008
|
|
| 2008
|
Diabetes Mellitus, Hypothalamic Hypoestrogenemia, and Coronary Artery Disease in Premenopausal Women (from the National Heart, Lung, and Blood Institute Sponsored WISE Study).
American Journal of Cardiology.
102:150-154.
2008
|
|
| 2008
|
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?.
Journal of Women's Health.
17:841-847.
2008
|
|
| 2008
|
Reply.
Journal of the American College of Cardiology.
51:1991.
2008
|
|
| 2008
|
Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease. The TNT (Treating to New Targets) Study.
Journal of the American College of Cardiology.
51:1448-1454.
2008
|
|
| 2008
|
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women.
Southern Medical Journal.
101:339-340.
2008
|
|
| 2008
|
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
Heart.
94:434-439.
2008
|
|
| 2008
|
Social networks and incident stroke among women with suspected myocardial ischemia.
Psychosomatic Medicine.
70:282-287.
2008
|
|
| 2008
|
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Journal of Translational Medicine.
6.
2008
|
|
| 2008
|
Angina pectoris: Reversal of the gender gap.
Circulation.
117:1505-1507.
2008
|
|
| 2008
|
Racial differences of lipoprotein subclass distributions in postmenopausal women
2008
|
|
| 2008
|
Task Force 10: Training in Preventive Cardiovascular Medicine.
Journal of the American College of Cardiology.
51:393-398.
2008
|
|
| 2008
|
Depression, the metabolic syndrome and cardiovascular risk.
Psychosomatic Medicine.
70:40-48.
2008
|
|
| 2008
|
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Mayo Clinic Proceedings.
83:870-879.
2008
|
|
| 2008
|
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation.
Journal of Clinical Endocrinology and Metabolism.
93:1276-1284.
2008
|
|
| 2008
|
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
Journal of Clinical Endocrinology and Metabolism.
93:4268-4275.
2008
|
|
| 2007
|
Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
Journal of Clinical Lipidology.
1:564-574.
2007
|
|
| 2007
|
Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia. The National Heart, Lung, and Blood Institute-Sponsored WISE Study.
Journal of the American College of Cardiology.
50:2044-2050.
2007
|
|
| 2007
|
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study.
Clinical Journal of the American Society of Nephrology.
2:1131-1139.
2007
|
|
| 2007
|
Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women.
Diabetic Medicine.
24:1156-1159.
2007
|
|
| 2007
|
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
New England Journal of Medicine.
357:1301-1310.
2007
|
|
| 2007
|
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.
ACP journal club.
147:1-9.
2007
|
|
| 2007
|
Influenza vaccination in secondary prevention - An opportunity missed.
Journal of Cardiopulmonary Rehabilitation and Prevention.
27:202-209.
2007
|
|
| 2007
|
Resistance exercise in individuals with and without cardiovascular disease: 2007 update: A scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.
Circulation.
116:572-584.
2007
|
|
| 2007
|
Secondary prevention outcomes among black and white cardiac rehabilitation patients.
American Heart Journal.
153:980-986.
2007
|
|
| 2007
|
Core components of cardiac rehabilitation/secondary prevention programs: 2007 Update - A scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism;....
Journal of Cardiopulmonary Rehabilitation and Prevention.
27:121-129.
2007
|
|
| 2007
|
Core components of cardiac rehabilitation/secondary prevention programs: 2007 update - A sci. statement from the Am. Heart Assoc. exercise, cardiac rehabilitation, and prevention comm., the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the Am. Assoc. of Cardiovasc. and Pulmonary Rehabil..
Circulation.
115:2675-2682.
2007
|
|
| 2007
|
Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
Journal of Women's Health.
16:228-234.
2007
|
|
| 2007
|
Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study.
Circulation.
115:576-583.
2007
|
|
| 2007
|
Outcomes at one-year follow-up of women and men with coronary artery disease discharged from cardiac rehabilitation: What benefits are maintained?.
Journal of Cardiopulmonary Rehabilitation and Prevention.
27:11-18.
2007
|
|
| 2007
|
Transthoracic echocardiography guided procedures in the catheterization laboratory.
2007
|
|
| 2006
|
Perspectives on dyslipidemia and coronary heart disease in women: An update.
Current Opinion in Cardiology.
21:602-607.
2006
|
|
| 2006
|
Obesity distribution and reproductive hormone levels in women: A report from the NHLBI-sponsored WISE study.
Journal of Women's Health.
15:836-842.
2006
|
|
| 2006
|
Migraines, Angiographic Coronary Artery Disease and Cardiovascular Outcomes in Women.
American Journal of Medicine.
119:670-675.
2006
|
|
| 2006
|
The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Circulation.
114:894-904.
2006
|
|
| 2006
|
Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study.
American Heart Journal.
152:126-135.
2006
|
|
| 2006
|
Phytoestrogens and lipoproteins in women.
Journal of Clinical Endocrinology and Metabolism.
91:2209-2213.
2006
|
|
| 2006
|
Menopause: Cause of consequence.
ACC Cardiosource Review Journal.
15:84-85.
2006
|
|
| 2006
|
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: Results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study.
European Heart Journal.
27:1408-1415.
2006
|
|
| 2006
|
Menopause and Cardiovascular Risk. Cause or Consequence?* * Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology..
Journal of the American College of Cardiology.
47:1984-1986.
2006
|
|
| 2006
|
Cardiac rehabilitation as secondary prevention center.
Coronary Artery Disease.
17:211-218.
2006
|
|
| 2006
|
Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Fertility and Sterility.
85:1425-1431.
2006
|
|
| 2006
|
Practical interpretation of 6-minute walk data using healthy adult reference equations.
Journal of Cardiopulmonary Rehabilitation and Prevention.
26:167-171.
2006
|
|
| 2006
|
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) study.
Journal of the American College of Cardiology.
47:S50-S58.
2006
|
|
| 2006
|
Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.
Journal of the American College of Cardiology.
47:S4-S20.
2006
|
|
| 2006
|
Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.
Journal of the American College of Cardiology.
47:S21-S29.
2006
|
|
| 2006
|
The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: The Heart and Estrogen-Progestin Replacement Study (HERS).
Annals of Epidemiology.
16:138-145.
2006
|
|
| 2006
|
Self-rated health among women with coronary disease: Depression is as important as recent cardiovascular events.
American Heart Journal.
152:921.e1-921.e7.
2006
|
|
| 2006
|
Training community health workers to reduce health disparities in Alabama's Black Belt: The Pine Apple Heart Disease and Stroke Project.
Family and Community Health.
29:89-102.
2006
|
|
| 2005
|
Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation.
American Heart Journal.
150:1140-1146.
2005
|
|
| 2005
|
Perspectives on dyslipidemia and coronary heart disease in women.
Journal of the American College of Cardiology.
46:1628-1635.
2005
|
|
| 2005
|
Women in cardiac rehabilitation: Outcomes and identifying risk for dropout.
American Heart Journal.
150:1052-1058.
2005
|
|
| 2005
|
Dietitian services are associated with improved patient outcomes and the MEDFICTS dietary assessment questionnaire is a suitable outcome measure in cardiac rehabilitation.
Journal of the Academy of Nutrition and Dietetics.
105:1533-1540.
2005
|
|
| 2005
|
Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.
ACP journal club.
142:813-820.
2005
|
|
| 2005
|
Depression and heart failure in patients with a new myocardial infarction.
American Heart Journal.
149:851-855.
2005
|
|
| 2004
|
Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: The Women's Angiographic Vitamin & Estrogen Trial.
American Heart Journal.
148:293-299.
2004
|
|
| 2004
|
Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B.
American Journal of Cardiology.
94:219-222.
2004
|
|
| 2004
|
The Effect of Vitamin Therapy on the Progression of Corona Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women.
Diabetes reviews (Alexandria, Va.).
27:925-930.
2004
|
|
| 2004
|
Determination of menopausal status in women: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Journal of Women's Health.
13:872-887.
2004
|
|
| 2004
|
Knowledge of heart attack symptoms in 20 US communities. Results from the rapid early action for coronary treatment community trial.
Preventive Medicine.
38:85-93.
2004
|
|
| 2004
|
Non-high-density lipoprotein cholesterol: an alternate target for lipid-lowering therapy..
Preventive Cardiology.
7.
2004
|
|
| 2004
|
Optimizing Risk Stratification in Cardiac Rehabilitation with Inclusion of a Comorbidity Index.
Journal of Cardiopulmonary Rehabilitation and Prevention.
24:8-15.
2004
|
|
| 2003
|
Personal, social, and physical environmental correlates of physical activity in rural African-American women in Alabama..
American Journal of Preventive Medicine.
25:30-37.
2003
|
|
| 2003
|
Metabolic syndrome and coronary angiographic disease progression: The Women's Angiographic Vitamin & Estrogen trial.
American Heart Journal.
146:439-445.
2003
|
|
| 2003
|
Non-high-density lipoprotein cholesterol and cardiovascular disease.
Current Opinion in Lipidology.
14:367-371.
2003
|
|
| 2003
|
Non-high-density lipoprotein cholesterol and cardiovascular disease..
Current Opinion in Lipidology.
14:367-371.
2003
|
|
| 2003
|
Exercise testing in heart failure: Maximal, submaximal, or both?.
Journal of the American College of Cardiology.
42:123-125.
2003
|
|
| 2003
|
Factors associated with the failure of patients to complete cardiac rehabilitation for medical and nonmedical reasons.
Journal of Cardiopulmonary Rehabilitation and Prevention.
23:281-289.
2003
|
|
| 2003
|
The 6-minute walk test: How important is the learning effect?.
American Heart Journal.
146:129-133.
2003
|
|
| 2003
|
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized control trial.
Evidence Based Eye Care.
4:82-83.
2003
|
|
| 2003
|
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: A report from the NHLBI-sponsored WISE study.
Journal of the American College of Cardiology.
41:413-419.
2003
|
|
| 2003
|
The 6-min walk test: A quick measure of functional status in elderly adults.
Chest.
123:387-398.
2003
|
|
| 2003
|
Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study: A randomized, double-blind, placebo-controlled trial.
ACP journal club.
138:1-9.
2003
|
|
| 2003
|
Hormone replacement therapy did not reduce the risk of cardiovascular events or non-cardiovascular disease outcomes in postmenopausal women in CHD.
Evidence-based Obstetrics and Gynecology.
5:51-52.
2003
|
|
| 2003
|
Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
American Heart Journal.
146:870-875.
2003
|
|
| 2003
|
Personal, social, and physical environmental correlates of physical activity in rural African-American women in Alabama.
American Journal of Preventive Medicine.
25:30-37.
2003
|
|
| 2003
|
Physical activity patterns among women in rural Alabama.
American Journal of Health Behavior.
27:311-321.
2003
|
|
| 2003
|
Women in cardiac rehabilitation..
Journal of the American Medical Women's Association (1972).
58:227-235.
2003
|
|
| 2002
|
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: The Women's Ischemia Syndrome Evaluation (WISE).
American Journal of Medicine.
113:723-727.
2002
|
|
| 2002
|
Women and coronary heart disease risk factors..
European Journal of Preventive Cardiology.
9:315-322.
2002
|
|
| 2002
|
Women's Angiographic Vitamin and Estrogen trial: Design and methods.
Contemporary Clinical Trials.
23:708-727.
2002
|
|
| 2002
|
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial.
Journal of the American Medical Association.
288:2432-2440.
2002
|
|
| 2002
|
Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).
Circulation.
106:2537-2542.
2002
|
|
| 2002
|
Lipoprotein abnormalities related to women's health.
American Journal of Cardiology.
90:77-84.
2002
|
|
| 2002
|
Lipoprotein abnormalities related to women's health..
American Journal of Cardiology.
90:77i-84i.
2002
|
|
| 2002
|
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II).
Journal of the American Medical Association.
288:49-57.
2002
|
|
| 2002
|
Prehospital delay in individuals with acute coronary disease: Concordance of medical records and follow-up phone interviews
2002
|
|
| 2002
|
ATS statement: Guidelines for the six-minute walk test.
American Journal of Respiratory and Critical Care Medicine.
166:111-117.
2002
|
|
| 2002
|
Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease
2002
|
|
| 2002
|
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/progestin Replacement Study (HERS).
Circulation.
105:2962-2967.
2002
|
|
| 2002
|
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.
Circulation.
105:2253-2258.
2002
|
|
| 2002
|
Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: The Cardiovascular Health Study.
Journal of the American Geriatrics Society.
50:416-423.
2002
|
|
| 2002
|
Hormone treatment - Misconceptions and agreements [4] (multiple letters).
European Heart Journal.
23:89-91.
2002
|
|
| 2002
|
Hormone treatment--misconceptions and agreements..
European Heart Journal.
23:89-91.
2002
|
|
| 2002
|
Lipid management in elderly patients: Clinical challenges and therapeutic strategies
2002
|
|
| 2002
|
Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease
2002
|
|
| 2002
|
Women and coronary heart disease risk factors.
European Journal of Preventive Cardiology.
9:315-322.
2002
|
|
| 2001
|
Treatment of dyslipidemia in pre- and postmenopausal women with and without known atherosclerotic cardiovascular disease.
Current Cardiology Reports.
3:401-407.
2001
|
|
| 2001
|
Enhancing recovery in coronary heart disease (ENRICHD) study intervention: Rationale and design.
Psychosomatic Medicine.
63:747-755.
2001
|
|
| 2001
|
Assessment of functional outcomes using the 6-minute walk test in cardiac rehabilitation: Comparison of patients with and without left ventricular dysfunction.
Journal of Cardiopulmonary Rehabilitation and Prevention.
21:221-224.
2001
|
|
| 2001
|
Estrogens, lipids and cardiovascular disease: No easy answers.
Journal of the American College of Cardiology.
37:431-433.
2001
|
|
| 2001
|
Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: The cardiovascular health study.
Diabetes reviews (Alexandria, Va.).
24:1233-1239.
2001
|
|
| 2000
|
Weight cycling and high-density lipoprotein cholesterol in women: Evidence of an adverse effect. A report from the NHLBI-sponsored WISE study.
Journal of the American College of Cardiology.
36:1565-1571.
2000
|
|
| 2000
|
Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group..
Journal of the American College of Cardiology.
36:1565-1571.
2000
|
|
| 2000
|
Physical activity and functional capacity measurement in women: A report from the NHLBI-sponsored WISE study.
Journal of Women's Health.
9:769-777.
2000
|
|
| 2000
|
Age and sex differences in presentation of symptoms among patients with acute coronary disease: The REACT trial.
Coronary Artery Disease.
11:399-407.
2000
|
|
| 2000
|
Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial. Rapid Early Action for Coronary Treatment..
Coronary Artery Disease.
11:399-407.
2000
|
|
| 2000
|
Effect of coronary angiography on use of lipid-lowering agents in women: A report from the women's ischemia syndrome evaluation (WISE) study.
American Journal of Cardiology.
85:1083-1088.
2000
|
|
| 2000
|
Correlates of high HDL cholesterol among women with coronary heart disease..
American Heart Journal.
139:288-296.
2000
|
|
| 2000
|
Advance directives in cardiac and pulmonary rehabilitation patients.
Journal of Cardiopulmonary Rehabilitation and Prevention.
20:340-345.
2000
|
|
| 2000
|
Correlates of high hdl cholesterol among women with coronary heart disease.
American Heart Journal.
139:288-296.
2000
|
|
| 2000
|
Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the elite ventricular function substudy.
American Heart Journal.
139:1081-1087.
2000
|
|
| 2000
|
Hormone replacement therapy in clinical cardiology.
Cardiology in Review.
8:57-64.
2000
|
|
| 2000
|
Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: Rapid early action for coronary treatment (REACT) trial.
Academic Emergency Medicine.
7:862-872.
2000
|
|
| 1999
|
Determining prognosis in congestive heart failure: role of the 6-minute walk test..
American Heart Journal.
138:593-596.
1999
|
|
| 1999
|
Antidiabetic treatment trends in a cohort of elderly people with diabetes: The Cardiovascular Health Study, 1989-1997.
Diabetes reviews (Alexandria, Va.).
22:736-742.
1999
|
|
| 1999
|
Women versus men regarding outcome of CABG or PTCA [6] (multiple letters).
Circulation.
99:1925-1926.
1999
|
|
| 1999
|
Referral patterns to a university-based cardiac rehabilitation program.
American Journal of Cardiology.
83:252-255.
1999
|
|
| 1999
|
Determining prognosis in congestive heart failure: Role of the 6-minute walk test.
American Heart Journal.
138:593-596.
1999
|
|
| 1998
|
Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary Treatment..
JAMA Internal Medicine.
158:2329-2338.
1998
|
|
| 1998
|
Knowledge of heart attack symptoms in a population survey in the United States: The REACT trial.
Archives of Internal Medicine.
158:2329-2338.
1998
|
|
| 1998
|
Better outcome for women compared with men undergoing coronary revascularization: A report from the bypass angioplasty revascularization investigation (BARI).
Circulation.
98:1279-1285.
1998
|
|
| 1998
|
Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collection.
Contemporary Clinical Trials.
19:391-403.
1998
|
|
| 1998
|
Atherosclerosis and the immune system.
JAMA Internal Medicine.
158:1395-1396.
1998
|
|
| 1998
|
Implications of coronary artery disease plus lower-extremity arterial disease for diabetics.
Cardiology in Review.
15:22-28.
1998
|
|
| 1998
|
Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry..
American Heart Journal.
135:1055-1062.
1998
|
|
| 1998
|
Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the coronary artery surgery study registry.
American Heart Journal.
135:1055-1062.
1998
|
|
| 1998
|
Predictors of readmission in patients with congestive heart failure
1998
|
|
| 1997
|
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (The Asymptomatic Cardiac Ischemia Pilot [ACIP] study).
American Journal of Cardiology.
80:1395-1401.
1997
|
|
| 1997
|
Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease: The Heart and Estrogen/Progestin Replacement Study (HERS).
Journal of the American Medical Association.
277:1281-1286.
1997
|
|
| 1997
|
Coronary artery disease in diabetic patients with lower-extremity arterial disease: Disease characteristics and survival: A report from the coronary artery surgery study (CASS) registry.
Diabetes reviews (Alexandria, Va.).
20:1381-1387.
1997
|
|
| 1997
|
Six-minute walk test in patients with cardiac dysfunction..
Cardiologia (Rome, Italy).
42:897-902.
1997
|
|
| 1996
|
Factors limiting the enrollment of women in a randomized coronary artery disease trial. The Asymptomatic Cardiac Ischemia Pilot Study (ACIP) Investigators.
1996
|
|
| 1996
|
Factors limiting the enrollment of women in a randomized coronary artery disease trial
1996
|
|
| 1996
|
Platelet activation and restenosis after coronary stenting: Flow cytometric detection of wound-induced platelet activation.
Coronary Artery Disease.
7:657-665.
1996
|
|
| 1995
|
Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: A CASS registry study.
Journal of the American College of Cardiology.
25:1000-1009.
1995
|
|
| 1995
|
Hypertension in women.
Current Opinion in Nephrology and Hypertension.
4:204-207.
1995
|
|
| 1994
|
Hormonal treatment of postmenopausal women.
New England Journal of Medicine.
331:550.
1994
|
|
| 1994
|
Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥65 years (report from the Coronary Artery Surgery Study [CASS] registry).
American Journal of Cardiology.
74:334-339.
1994
|
|
| 1994
|
In Reply: The Predictive Capabilities of Clinical Tests: The 6-Minute Walk.
Journal of the American Medical Association.
271:662.
1994
|
|
| 1994
|
Atherogenicity of postprandial lipoproteins and coronary heart disease.
Endocrinologist.
4:359-372.
1994
|
|
| 1994
|
Primary and secondary prevention of ischemic heart disease.
Current Opinion in Cardiology.
9:417-427.
1994
|
|
| 1994
|
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction.
Journal of the American College of Cardiology.
23:393-400.
1994
|
|
| 1994
|
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunction.
Journal of the American College of Cardiology.
23:1410-1420.
1994
|
|
| 1993
|
Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction.
Journal of the American Medical Association.
270:1702-1707.
1993
|
|
| 1993
|
Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators..
Journal of the American Medical Association.
270:1702-1707.
1993
|
|
| 1993
|
Efficacy studies in coronary rehabilitation.
Cardiology Clinics.
11:333-347.
1993
|
|
| 1992
|
Frequency of stress-induced thallium-201 defects in patients with patent internal mammary artery to the left anterior descending coronary artery graft.
American Journal of Cardiology.
70:399-400.
1992
|
|
| 1992
|
Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heart.
Journal of Heart and Lung Transplantation.
11:584-586.
1992
|
|
| 1992
|
Renal, hemodynamic, and electrocardiographic effects of low versus high osmolality contrast agents on the transplanted heart..
Journal of Heart and Lung Transplantation.
11:584-586.
1992
|
|
| 1991
|
31P NMR spectroscopy in chronic adriamycin cardiotoxicity.
Magnetic Resonance in Medicine.
17:69-81.
1991
|
|
| 1989
|
Dual connection of the left anterior descending coronary artery to the left and right coronary arteries.
Catheterization and Cardiovascular Interventions.
16:168-172.
1989
|
|
| 1989
|
Nuclear magnetic resonance imaging of the cardiovascular system.
Current Opinion in Cardiology.
4:845-852.
1989
|
|
| 1989
|
Overview of cardiovascular nuclear magnetic resonance imaging.
Cardiology Clinics.
7:631-649.
1989
|
|
| 1989
|
The value of cine nuclear magnetic resonance imaging for assessing regional ventricular function.
Journal of the American College of Cardiology.
14:1721-1729.
1989
|
|
| 1988
|
Cardiac matrix alterations induced by adriamycin.
American Journal of Pathology.
133:298-305.
1988
|
|
| 1988
|
Atrial septal defect in older adults: Atypical radiographic appearances.
Radiology.
167:123-127.
1988
|
|
